Description
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Product Unit Size | Cost | Quantity | Stock |
---|
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Cas No. | 1202759-32-7 |
---|---|
Purity | ≥98% |
Formula | C26H22FN7O3 |
Formula Wt. | 499.50 |
Chemical Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
IUPAC Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
Synonym | CNX774 |
Solubility | DMSO 100 mg/mL (200.2 mM) Ethanol 2 mg/mL (4.0 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Akinleye A, Chen Y, Mukhi N, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol. 2013 Aug 19;6:59. PMID: 23958373.
Bisphosphonate; FPPS inhibitor.
PARP inhibitor.
5-HT3 antagonist.
NSAID; COX-1/2 and PDE inhibitor.
PI3K and mTOR inhibitor.
Potential AhR binding agent.
Found in Streptomyces; proteasome inhibitor.
EGFR inhibitor.
Wee1 inhibitor.
Phenol found in Psoralea coryfolia.
EGFR (WT, T790M) inhibitor.
5-α-Reductase inhibitor.
Benzoylurea, insect growth regulator; chitin sy...
Imidazoline and α2-adrenergic agonist, Nav1.7 ...
Inhibitor of EGFR, HER2, VEGFR2, and FLT3.
Pyrrolopyrimidine; Akt inhibitor.
Metal ion chelator, viral DNA polymerase inhibi...
Mycotoxin produced by species of Aspergillus; D...
Macrocyclic lactone avermectin; GABA antagonist...
Triazolopyrazine; c-MET inhibitor.